secwatch.observer — SEC 8-K summary
======================================

Issuer:     MAIA Biotechnology, Inc. (MAIA)
CIK:        0001878313
Form:       8-K
Filed at:   2023-09-01T23:59:59+00:00
Accession:  0001193125-23-227712
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MAIA Biotechnology enters $7M ATM equity facility with ThinkEquity LLC
----------------------------------------------------------------------

- MAIA may sell up to $7,000,000 of common stock at market prices through ThinkEquity as sales agent.
- Fixed commission rate of 3.0% of gross proceeds; agent also receives expense reimbursement up to $50,000 upfront.
- Sales are subject to a placement notice process and can be suspended by either party on 10 days' notice.
- Agreement filed as Exhibit 10.1; shares offered pursuant to effective S-3 shelf registration statement.
- No obligation to sell; proceeds expected for general corporate purposes per prospectus supplement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1878313/000119312523227712/0001193125-23-227712-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1878313/000119312523227712/d482665d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-227712

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer